Category: 3. Business

  • Favourable Signals For Lakes Blue Energy: Numerous Insiders Acquired Stock

    Favourable Signals For Lakes Blue Energy: Numerous Insiders Acquired Stock

    Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in the case of Lakes Blue Energy NL (ASX:LKO), it sends a favourable message to the company’s shareholders.

    While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

    This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

    Notably, that recent purchase by Roland Sleeman is the biggest insider purchase of Lakes Blue Energy shares that we’ve seen in the last year. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of AU$1.13. Because the shares were purchased at a lower price, this particular buy doesn’t tell us much about how insiders feel about the current share price.

    Lakes Blue Energy insiders may have bought shares in the last year, but they didn’t sell any. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

    Check out our latest analysis for Lakes Blue Energy

    ASX:LKO Insider Trading Volume August 9th 2025

    Lakes Blue Energy is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.

    Over the last three months, we’ve seen significant insider buying at Lakes Blue Energy. Not only was there no selling that we can see, but they collectively bought AU$636k worth of shares. That shows some optimism about the company’s future.

    Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. Our data indicates that Lakes Blue Energy insiders own about AU$7.6m worth of shares (which is 9.9% of the company). We do note, however, it is possible insiders have an indirect interest through a private company or other corporate structure. Overall, this level of ownership isn’t that impressive, but it’s certainly better than nothing!

    It’s certainly positive to see the recent insider purchases. And an analysis of the transactions over the last year also gives us confidence. But we don’t feel the same about the fact the company is making losses. While the overall levels of insider ownership are below what we’d like to see, the history of transactions imply that Lakes Blue Energy insiders are reasonably well aligned, and optimistic for the future. In addition to knowing about insider transactions going on, it’s beneficial to identify the risks facing Lakes Blue Energy. Be aware that Lakes Blue Energy is showing 5 warning signs in our investment analysis, and 3 of those don’t sit too well with us…

    Continue Reading

  • Uber Technologies, Inc. (UBER) “Is Just A Steady Good Story,” Says Jim Cramer

    Uber Technologies, Inc. (UBER) “Is Just A Steady Good Story,” Says Jim Cramer

    We recently published 10 Stocks Jim Cramer Mentioned As He Talked About “Love Lost” Between Microsoft & OpenAI. Uber Technologies, Inc. (NYSE:UBER) is one of the stocks Jim Cramer recently discussed.

    Uber Technologies, Inc. (NYSE:UBER) is a ride-sharing company whose shares have gained 42% year-to-date. The firm has benefited from the growth in ridesharing services, which include a partnership between it and Waymo. Uber Technologies, Inc. (NYSE:UBER)’s shares gained 3.9% after the firm’s second-quarter earnings report saw its gross bookings of $46.8 billion beat analyst estimates of $46.4 billion. During the quarter, the firm’s 180 million monthly active platform users also beat analyst estimates of 176.6 million. Here’s what Cramer said about Uber Technologies, Inc. (NYSE:UBER) after the earnings:

    “Look this is just a steady good story. Boy the stock was down five this morning. I think it was from people who didn’t understand the [inaudible] but this could be just throws off cash like no tomorrow. I thought that was really interesting because remember when they used to lose cash like no tomorrow?”

    Uber Technologies, Inc. (UBER) “Is Just A Steady Good Story,” Says Jim Cramer

    Photo by Paul Hanaoka on Unsplash

    Cramer wagered a guess at Uber Technologies, Inc. (NYSE:UBER)’s future share price in his earlier remarks. Here is what he said:

    “Okay, stock’s up, stock’s up 45%. I got so many, I got a lot of stocks that are down. Those are the ones that gotta wake up. I think Uber’s going to $200. I just say you go buy more here. That’s the only solution that I see.”

    While we acknowledge the potential of UBER as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

    READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

    Disclosure: None. This article is originally published at Insider Monkey.

    Continue Reading

  • UAE: No more power banks on Emirates flights? What to know about new policy starting October 1 – MSN

    1. UAE: No more power banks on Emirates flights? What to know about new policy starting October 1  MSN
    2. Emirates sets new rules for power banks onboard flights from October 1  Khaleej Times
    3. Powerbank use banned aboard flights: Why lithium-ion batteries pose a fire risk  Gulf News
    4. Major Airline Announces New Ban After Series of Mid-Air Scares  Men’s Journal
    5. Another airline restricts the use of portable chargers onboard. What to know.  USA Today

    Continue Reading

  • 11 Money Rules To Unlearn and Upgrade To Grow Your Wealth, According to a Gen Z Money Expert

    11 Money Rules To Unlearn and Upgrade To Grow Your Wealth, According to a Gen Z Money Expert

    Volodymyr Kalyniuk / iStock.com

    Much of the money advice many people were given growing up doesn’t really work anymore. Buying a home in your 20s and marrying rich might’ve made sense back then, but times have changed.

    Read More: The No. 1 Key To Wealth, According To Wahei Takeda, the ‘Warren Buffett of Japan’

    Find Out: The New Retirement Problem Boomers Are Facing

    Gen Z finance creator Taylor Price is helping people rethink the old-school money mindset. In one of her recent TikToks, she broke down 11 traditional money rules and replaced them with more realistic strategies for building wealth.

    Price’s new rule: Don’t let your lifestyle inflate with your income.

    Living within your means is important, but you should also be aware of lifestyle creep. That’s when your expenses rise every time your paycheck does. Instead of upgrading your car, apartment or wardrobe every time you get a raise, keep your core expenses the same and funnel the extra money toward investing or saving.

    Check Out: 3 Signs You’ve ‘Made It’ Financially, According to Financial Influencer Genesis Hinckley

    Price’s new rule: Invest at least 20% of what you earn no matter what.

    Saving won’t get you far if your money is just sitting in a low-interest savings account. Price’s advice is to invest at least 20% of your income into something that grows. The average savings account rate is 0.38% as of August 7, 2025, per CNBC, while the stock market has seen an average return of about 10% annually, per Experian.

    Price’s new rule: Build a spending plan that supports your goals.

    Budgets can feel pretty restrictive, whereas a spending plan can feel more empowering and teach you to be intentional with your money. With a spending plan, you can allocate money toward things that actually matter to you, like travel, investing or building a business, while still covering your essentials.

    Price’s new rule: Utilize credit cards in a responsible way.

    Credit cards can be beneficial if you actually know how to use them. If you use them correctly, they can help you build credit and earn rewards. Just make sure to pay off your balance in full every month and never spend more than what you can afford.

    To use credit cards responsibly, Capital One recommended understanding your card’s terms, monitoring credit limits and reviewing monthly statements.

    Price’s new rule: Buy a home only when it adds freedom, not stress.

    Owning a home used to be the American dream, but it may not make financial sense for everyone. Don’t feel pressured to buy if it’s going to leave you house poor or lock you into a place you don’t love.


    Continue Reading

  • Is the oil price party already over before it’s begun? – The Times

    Is the oil price party already over before it’s begun? – The Times

    1. Is the oil price party already over before it’s begun?  The Times
    2. Press Releases  Organization of the Petroleum Exporting Countries
    3. Oil Prices Face Pressure From Weak Data And Rising Supply  Finimize
    4. April 2023 OPEC+ Tranche ‘Next in Focus’, Analysts Say  Rigzone
    5. Eight OPEC+ countries raise production by 547,000 bpd  The Express Tribune

    Continue Reading

  • Cybersecurity

    Cybersecurity

    In the 21st century, wars are no longer fought only on battlefields. They are fought silently — through codes, networks and invisible data streams. This is the era of cybersecurity, a battleground where the enemy could be thousands of miles away, yet capable of bringing your life to a halt in seconds.


    Last year alone, cybercrime cost the global economy an estimated $8 trillion. Hackers have targeted everything from multinational corporations to hospital systems, from government databases to small family-owned businesses — and even the smartphones in our pockets.


    Cyberattacks are not just about stolen money. They can destroy reputations, paralyse operations, and in some cases, even endanger lives. The threats include phishing emails designed to look like they’re from your bank, ransomware that holds your files hostage until you pay, deepfake scams that use AI to mimic voices and faces for fraud and data breaches leaking personal details for identity theft.


    Your personal photos, business documents, bank accounts, and even your identity are valuable assets in the black market of the dark web. Criminals don’t need to break into your home anymore; they can rob you without leaving their couch.


    Experts recommend adopting these digital safety habits: Create strong, unique passwords and change them once or twice a month; enable Two-Factor Authentication (2FA) for all important accounts, think before you click — especially on suspicious links or attachments even sent from your beloved once; update your devices and software to patch security holes; and back up important data regularly on a secure cloud or offline storage.


    Governments worldwide are passing stricter laws to punish cybercrime, yet laws alone are not enough. Awareness and personal responsibility are the true shields in this invisible war. The next time you go online, remember: You are both a soldier and a target in the silent war of the digital age. Stay alert. Stay secure.


    Javeria Aara

    Hyderabad

     

    Continue Reading

  • Toyota Yaris 1.3 all variants updated installment plans for August 2025

    Toyota Yaris 1.3 all variants updated installment plans for August 2025

    KARACHI – Toyota Yaris 1.3 continues to make waves in Pakistan with its elegant looks and impressive performance in all weathers.

    As the vehicle prices registered an increase recently following the imposition of NEV levy by the federal government, several leading banks are offering easy monthly installment and residual value installment plan to help buyers drive away their favourite Yaris 1.3.

    The United Bank Limited (UBL) has introduced attractive installment plans for customers interested in purchasing the Toyota Yaris 1.3 variants through its financing scheme.

    The offer aims to make vehicle ownership more accessible with minimal down payments and flexible repayment options.

    Toyota Yaris 1.3 GLI MT

    The Toyota Yaris GLI MT 1.3, priced at Rs4,649,000. Under the latest installment plan, the buyer needs to deposit an equity amount of Rs1,673,640, with a financing amount of Rs2,975,360. Easy Monthly installments start from Rs102,415, while the residual value (RV) installment stands at Rs69,184.

    Toyota Yaris 1.3 ATIV MT

    The Toyota Yaris ATIV MT 1.3, is available at Rs4,829,000 in Pakistan. It comes with an equity requirement of Rs1,835,020 and financing of Rs2,993,980 under the UBL car installment scheme. Customers can avail a standard monthly installment of Rs103,056 and an RV installment of Rs69,289.

    Toyota Yaris 1.3 GLI CVT

    The price of Toyota Yaris GLI CVT 1.3, stood at Rs4,809,000, while the equity amount is Rs1,827,420, with financing of Rs2,981,580. The standard EMI is Rs102,629, and the RV installment is Rs69,328.

    Toyota Yaris 1.3 ATIV CVT

    The Toyota Yaris ATIV CVT 1.3 is priced at Rs. 5,179,000. Under the UBL plan, the buyer requires to deposit Rs 2,226,970 as equity while the financing amount stood at Rs2,952,030.

    This variant comes with a monthly installment of Rs101,612 and an RV installment of Rs68,641.

    Continue Reading

  • Early assessment of treatment response in primary biliary cholangitis: key to timely management | BMC Gastroenterology

    Early assessment of treatment response in primary biliary cholangitis: key to timely management | BMC Gastroenterology

  • European Association for the Study of the Liver. Electronic address eee, European association for the study of the L: EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145–72.

    Google Scholar 

  • Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary biliary cholangitis: 2021 practice guidance update from the American association for the study of liver diseases. Hepatology. 2022;75(4):1012–3.

    PubMed 

    Google Scholar 

  • Gazda J, Drazilova S, Janicko M, Jarcuska P. The Epidemiology of Primary Biliary Cholangitis in European Countries: A Systematic Review and Meta-Analysis. Can J Gastroenterol Hepatol. 2021;2021:9151525.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Muratori L, Parola M, Ripalti A, Robino G, Muratori P, Bellomo G, Carini R, Lenzi M, Landini MP, Albano E, et al. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut. 2000;46(4):553–61.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Granito A, Muratori P, Muratori L, Pappas G, Cassani F, Worthington J, Guidi M, Ferri S, C DEM, Lenzi M, et al. Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim-like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis. Aliment Pharmacol Ther. 2006;24(11–12):1575–83.

    PubMed 

    Google Scholar 

  • Granito A, Muratori P, Quarneti C, Pappas G, Cicola R, Muratori L. Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Rev Mol Diagn. 2012;12(1):65–74.

    PubMed 

    Google Scholar 

  • Granito A, Yang WH, Muratori L, Lim MJ, Nakajima A, Ferri S, Pappas G, Quarneti C, Bianchi FB, Bloch DB, et al. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. Am J Gastroenterol. 2010;105(1):125–31.

    PubMed 

    Google Scholar 

  • Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E, International Autoimmune Hepatitis G. Overlap syndromes: the international autoimmune hepatitis group (IAIHG) position statement on a controversial issue. J Hepatol. 2011;54(2):374–85.

    PubMed 

    Google Scholar 

  • Muratori P, Granito A, Pappas G, Muratori L. Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients. Hepatology. 2009;49(5):1782–3. author reply 1783.

    PubMed 

    Google Scholar 

  • Drazilova S, Koky T, Macej M, Janicko M, Simkova D, Tsedendamba A, Komarova S, Jarcuska P. Pruritus, fatigue, osteoporosis and dyslipoproteinemia in Pbc patients: A clinician’s perspective. Gastroenterol Insights. 2024;15(2):419–32.

    Google Scholar 

  • Gazda J, Drazilova S, Gazda M, Janicko M, Koky T, Macej M, Carbone M, Jarcuska P. Treatment response to ursodeoxycholic acid in primary biliary cholangitis: A systematic review and meta-analysis. Dig Liver Dis. 2022. https://doi.org/10.1016/j.dld.2022.12.010.

  • Gazda J, Drazilova S, Janicko M, Grgurevic I, Filipec Kanizaj T, Koller T, Bodorovska B, Bozin T, Mijic M, Rob Z, et al. Prognostic factors in primary biliary cholangitis: A retrospective study of joint Slovak and Croatian cohort of 249 patients. J Pers Med. 2021;11(6). https://doi.org/10.3390/jpm11060495.

  • Harms MH, van Buuren HR, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, Hirschfield GM, Pares A, Floreani A, Mayo MJ, et al. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. J Hepatol. 2019;71(2):357–65.

    PubMed 

    Google Scholar 

  • Nevens F, Trauner M, Manns MP. Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases(dagger). J Hepatol. 2023;78(2):430–41.

    PubMed 

    Google Scholar 

  • Kumagi T, Guindi M, Fischer SE, Arenovich T, Abdalian R, Coltescu C, Heathcote EJ, Hirschfield GM. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol. 2010;105(10):2186–94.

    PubMed 

    Google Scholar 

  • Murillo Perez CF, Harms MH, Lindor KD, van Buuren HR, Hirschfield GM, Corpechot C, van der Meer AJ, Feld JJ, Gulamhusein A, Lammers WJ, et al. Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase. Am J Gastroenterol. 2020;115(7):1066–74.

    PubMed 

    Google Scholar 

  • Nevens F, Andreone P, Mazzella G, Strasser SI, Bowlus C, Invernizzi P, Drenth JP, Pockros PJ, Regula J, Beuers U, et al. A Placebo-Controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med. 2016;375(7):631–43.

    PubMed 

    Google Scholar 

  • Bowlus CL, Pockros PJ, Kremer AE, Pares A, Forman LM, Drenth JPH, Ryder SD, Terracciano L, Jin Y, Liberman A, et al. Long-Term obeticholic acid therapy improves histological endpoints in patients with primary biliary cholangitis. Clin Gastroenterol Hepatol. 2020;18(5):1170–8. e1176.

    PubMed 

    Google Scholar 

  • Trauner M, Nevens F, Shiffman ML, Drenth JPH, Bowlus CL, Vargas V, Andreone P, Hirschfield GM, Pencek R, Malecha ES, et al. Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study. Lancet Gastroenterol Hepatol. 2019;4(6):445–53.

    PubMed 

    Google Scholar 

  • Londono MC, Diaz-Gonzalez A. Predicting liver-related serious adverse events in patients with primary biliary cholangitis-related cirrhosis treated with obeticholic acid. Liver Int. 2022;42(11):2356–9.

    PubMed 

    Google Scholar 

  • Kowdley KV, Hirschfield GM, Coombs C, Malecha ES, Bessonova L, Li J, Rathnayaka N, Mells G, Jones DE, Trivedi PJ, et al. COBALT: A confirmatory trial of obeticholic acid in primary biliary cholangitis with placebo and external controls. Am J Gastroenterol. 2024. https://doi.org/10.14309/ajg.0000000000003029.

  • Corpechot C, Chazouilleres O, Rousseau A, Le Gruyer A, Habersetzer F, Mathurin P, Goria O, Potier P, Minello A, Silvain C, et al. A Placebo-Controlled trial of Bezafibrate in primary biliary cholangitis. N Engl J Med. 2018;378(23):2171–81.

    PubMed 

    Google Scholar 

  • Cancado GGL, Couto CA, Guedes LV, Braga MH, Terrabuio DRB, Cancado ELR, Ferraz MLG, Villela-Nogueira CA, Nardelli MJ, Faria LC, et al. Fibrates for the treatment of primary biliary cholangitis unresponsive to ursodeoxycholic acid: an exploratory study. Front Pharmacol. 2021;12:818089.

    PubMed 

    Google Scholar 

  • Li C, Zheng K, Chen Y, He C, Liu S, Yang Y, Li M, Zeng X, Wang L, Zhang F. A randomized, controlled trial on Fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid. Ther Adv Chronic Dis. 2022;13:20406223221114198.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Hirschfield GM, Beuers U, Kupcinskas L, Ott P, Bergquist A, Farkkila M, Manns MP, Pares A, Spengler U, Stiess M, et al. A placebo-controlled randomised trial of Budesonide for PBC following an insufficient response to UDCA. J Hepatol. 2021;74(2):321–9.

    PubMed 

    Google Scholar 

  • Hirschfield GM, Bowlus CL, Mayo MJ, Kremer AE, Vierling JM, Kowdley KV, Levy C, Villamil A, Ladron de Guevara Cetina AL, Janczewska E et al. A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis. N Engl J Med. 2024;390(9):783–794.

  • Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, et al. Efficacy and safety of Elafibranor in primary biliary cholangitis. N Engl J Med. 2024;390(9):795–805.

    PubMed 

    Google Scholar 

  • Vuppalanchi R, Caldwell SH, Pyrsopoulos N, deLemos AS, Rossi S, Levy C, Goldberg DS, Mena EA, Sheikh A, Ravinuthala R, et al. Proof-of-concept study to evaluate the safety and efficacy of Saroglitazar in patients with primary biliary cholangitis. J Hepatol. 2022;76(1):75–85.

    PubMed 

    Google Scholar 

  • Mayo MJ, Wigg AJ, Leggett BA, Arnold H, Thompson AJ, Weltman M, Carey EJ, Muir AJ, Ling L, Rossi SJ, et al. NGM282 for treatment of patients with primary biliary cholangitis: A multicenter, randomized, Double-Blind, Placebo-Controlled trial. Hepatol Commun. 2018;2(9):1037–50.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Yang C, Guo G, Li B, Zheng L, Sun R, Wang X, Deng J, Jia G, Zhou X, Cui L, et al. Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion. Hepatol Int. 2023;17(1):237–48.

    PubMed 

    Google Scholar 

Continue Reading

  • Emirates to ban power bank use onboard after safety incidents – Aviation24.be

    1. Emirates to ban power bank use onboard after safety incidents  Aviation24.be
    2. Emirates sets new rules for power banks onboard flights from October 1  Khaleej Times
    3. Major Airline Announces New Ban After Series of Mid-Air Scares  Men’s Journal
    4. Another airline restricts the use of portable chargers onboard. What to know.  USA Today
    5. Video: Emirates bans power bank use after smoke fills KLM flight from Brazil this week  NL Times

    Continue Reading

  • A voice breaking from the Fed ranks just heightened her push for cutting interest rates fast

    A voice breaking from the Fed ranks just heightened her push for cutting interest rates fast

    By Mark DeCambre

    Fed Gov. Bowman warns jobs market is weakening and urges faster action ahead of September Fed meeting.

    Fed Gov. Michelle Bowman is breaking ranks with Fed Chairman Jerome Powell and the rest of the central bank.

    Fed Gov. Michelle Bowman is doubling down on her call to cut interest rates, urging the central bank to move faster to protect what she sees as a weakening jobs market.

    “Taking action at last week’s meeting would have proactively hedged against the risk of a further erosion in labor market conditions and a further weakening in economic activity,” Bowman said Saturday in a speech at a bankers’ conference in Colorado Springs, Colo.

    Her remarks, delivered just over a week after she and Fed. Gov. Christopher Waller dissented from the Fed’s decision to hold rates steady in late July, add urgency to her push. That dissent was the first time in 32 years that two governors opposed the majority decision.

    Once a firm opponent of lowering rates for fear of locking in high inflation, Bowman now says the greater risk is a faltering labor picture in the U.S. Over the weekend, she signaled she would support moving more quickly-and perhaps more decisively-to cut rates if labor data takes another hit before the Fed’s September meeting.

    “I see the risk that a delay in taking action could result in a deterioration in the labor market and a further slowing in economic growth,” she said on Saturday.

    For borrowers and investors, the question may now be less about if rates will be cut next month and more about the pace of rate reductions to follow-a shift that could ripple from mortgages to credit cards and across the broader economy. Futures markets overwhelmingly expect the first move to be a quarter-point cut from current levels at a range of 4.25%-4.50%.

    -Mark DeCambre

    This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. 

    
  (END) Dow Jones Newswires
    

    
  08-09-25 1431ET
    

    Copyright (c) 2025 Dow Jones & Company, Inc.

    Continue Reading